Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0820
+0.0020 (2.50%)
Sep 17, 2026, 3:56 PM AEST
Rhythm Biosciences Company Description
Rhythm Biosciences Limited, a medical diagnostics company, develops and commercialises medical diagnostic tests for cancer detection in Australia and the United States.
The company offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development.
Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.
Rhythm Biosciences Limited
| Country | Australia |
| Founded | 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | David Atkins |
Contact Details
Address: Bio21 Institute Parkville, VIC 3010 Australia | |
| Phone | 61 3 8256 2880 |
| Website | rhythmbio.com |
Stock Details
| Ticker Symbol | RHY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000RHY2 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. David Atkins M.B.A., Ph.D. | Chief Executive Officer and Director |